Projects

Projects

 

Sl.No. Name of Department Project Name Period of Study Funding Agency

1

FORENSIC MEDICINE & TOXICOLOGY Serum Phospholipase A2, Hyaluronidase , Metalloprotease, Serine Protease and 3FT- Three-finger Toxin as biomarkers for diagnosis and confirmation of snake envenomation: A hospital based study Starting Year-2021
Proposed Year of completion-2023
ICMR, New Delhi

2

BIOCHEMISTRY Study to Determine the Therapeutic Potential of Natural products, Aegel marmelos (L.), Bael in the treatment of Covid-19 patients Starting Year- Nov 2020
Proposed Year of completion-2023
Health & Family Welfare Department, Govt of Odisha.

3

CARDIOLOGY NATIONAL HEART FAILURE REGISTRY 3 years.
Started 18.09.2018
ICMR

4

CLINICAL HEMATOLOGY WFH Hemophilia Treatment Center Twinning Programme 2 Years (Upto 2021) WFH(World Federation of Hemophilia)
Sociological impact and Tribal Health: A study on Epidemiological Diversity of Thalassaemia mutation among Tribes and Impact of Sociological Influence 5Years (Starting year 2017) Ministry of Science and Technology, Govt. of India

5

MICROBIOLOGY Development & Optimization of a novel point of care Assay for human leptospirosis 3 Years (2021-24) DHR

6

OBSTETRICS & GYNAECOLOGY TITLE: NATIONAL STRATEGY OF COVID-19 INFECTION ON PREGNANCY AND THEIR NEONATES Starting Year-June 2020
Proposed Year of completion-2023
ICMR
TITLE: MATERNAL NEAR MISS REVIEW Starting Year-November – 2020
Proposed Year of completion-2023
ICMR
TITLE: The WHO ACTION (Antenatal Corticos Teroids for Improving Outcomes in preterm Newborns) Trials -ACTION I AND ACTION II Starting Year-November – 2018
Year of completion-2020
WHO
TITLE: SCOPE – Standardization of COVID in Pregnancy Starting Year-April  2020
Proposed Year of completion December-2020
WHO Country Office

7

PULMONARY MEDICINE A Phase III, Randomized, Double-blind, Placebocontrolled Trial to Evaluate the Efficacy and Safety of VPM1002 and Immuvac Vaccines in Preventing Tuberculosis (TB) in Healthy Household Contacts of Newly Diagnosed Sputum Positive Pulmonary TB Patients 38 months
(03.20.2018 to 15.11.2020)
ICMR
An Open-Label, Non-Randomized, Two-Stage, Dose-Finding Study Of Verapamil Tablet Formulation In Adult Tuberculosis Patients In Continuation Phase Of Anti-Tuberculosis Treatment 38 months
(03.20.2018 to 15.11.2020)
ICMR, New Delhi

8

RHEUMATOLOGY Role of vitamin D3 in SLE:A double blind randomized controlled trial
Duration
2017 to 2020 ICMR
Multi-institutional network programme on SLE: understanding the diversity of SLE 2018 to 2023 DBT

9

COMBINED MULTI-DEPARTMENTAL PROJECTS
BIOCHEMISTRY,
OBSTETRICS & GYNAECOLOGY,
HAEMATOLOGY
Detection of Genetic  mutation in Chorionic Villous Sample (CVS) for prenatal diagnosis of Thalassemia. Starting Year-December – 2020
Proposed Year of completion -2025
NHM in collaboration with CMC Vellore
BIOCHEMISTRY,
OBSTETRICS & GYNAECOLOGY,
HAEMATOLOGY
Haemoglobinopathy detection from cord blood. Starting Year-December – 2020
Proposed Year of completion -2025
NHM in collaboration with CMC Vellore
COMMUNITY MEDICINE & PLASTIC SURGERY Situational analysis of burn injury under the guidance of AIIMS, Delhi. 2019 to 2021 Ministry of H & FW, Govt. of India.
NEUROLOGY & GENERAL MEDICINE DEVELOPMENT OF POPULATION BASED STROKE REGISTRY (PBSR) Started-01.03.2017

Proposed Year of completion-2025

Department of Health Research (DHR), ICMR.
NEUROLOGY & GENERAL MEDICINE HTA OF NATIONAL STROKE CARE REGISTRY PROGRAMME DEVELOPMENT OF HOSPITAL BASED STROKE REGISTRIES IN DIFFERENT REGIONS OF INDIA Starting Year-December 2018

Proposed Year of completion-2023

Department of Health Research (DHR), ICMR.
PROJECT NAME FUNDING AGENCY FUNDS RECEIVED FUNDS RECEIVED FUNDS RECEIVED
2017-18 2018-19 2019-20
PBSR (Neurology and Med) ICMR 1943500 300000 941071
HBSR (Neurology and Med) ICMR 500000
DIABETES MELLITUS YOUNG (Med) ICMR 1059704 1008016 386407
INDIA B STUDY (Med) ICMR 4958000
HUMAN REPRODUCTION RESOURCE CENTER (OBG) ICMR 822640 1476919 2602887
822641 1260916
1586987
VIT-D RHEUMATOLOGY ICMR 337284 509575 197895
700000
ACTION TRIAL (O & G) WHO 636257 760000
791867 636257
236257
CHAMPION TRIAL (O & G) WHO 160650 180900
774987 39760
Sociologic impact and Tribal Health (Haematology) DST 438000
Hemophilia Treatment Centre Twinning Programme (Haematology) WFH 140000
TOTAL 8646393 6344210 11218774